Abnormally high expression of proteasome activator-γ in thyroid neoplasm

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 3, 2003, Pages 1374-1383

  Okamura, Tomohisa ^a   Taniguchi, Shin Ichi ^a   Ohkura, Tsuyoshi ^a   Yoshida, Akio ^a   Shimizu, Hideki ^a   Sakai, Mitsue ^a   Maeta, Hiroyuki ^a   Fukui, Hiroko ^a   Ueta, Yoshihiko ^a   Hisatome, Ichiro ^a   Shigemasa, Chiaki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; ELASTOLACTACYSTIN BETA LACTONE; LACTACYSTIN; LACTONE; PROTEASOME; PROTEASOME ACTIVATOR GAMMA; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANAPLASTIC CARCINOMA; ARTICLE; CELL CYCLE; CELL NUCLEUS; CONTROLLED STUDY; DNA SYNTHESIS; GENE EXPRESSION; GENE OVEREXPRESSION; GOITER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCORING SYSTEM; SQUAMOUS CELL METAPLASIA; THYROID CANCER; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL DIVISION; HUMANS; IMMUNOHISTOCHEMISTRY; MUSCLE PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; PROTEINS; THYROID NEOPLASMS;

EID: 0037340221     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021413     Document Type: Article

References (48)

1. Hershko A, Ciechanover A 1998 The ubiquitin system. Annu Rev Biochem 67:425-479
2. Rechsteiner M, Hoffman L, Dubiel W 1993 The multicatalytic and 26 S proteases. J Biol Chem 268:6065-6068
3. Peters JM 1994 Proteasomes: protein degradation machines of the cell. Trends Biochem Sci 19:377-382
4. Hilt W, Wolf DH 1996 Proteasomes: destruction as a programme. Trends Biochem Sci 21:96-102
5. Coux O, Tanaka K, Goldberg AL 1996 Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65:801-847
6. Hoffman L, Rechsteiner M 1996 Regulatory features of multicatalytic and 26S proteases. Curr Top Cell Regul 34:1-32
7. Adams GM, Falke S, Goldberg AL, Slaughter CA, DeMartino GN, Gogol EP 1997 Structural and functional effects of PA700 and modulator protein on proteasomes. J Mol Biol 273:646-657
8. Ahn JY, Tanahashi N, Akiyama K, Hisamatsu H, Noda C, Tanaka K, Chung CH, Shibmara N, Willy PJ, Mott JD, Slaughter CA, DeMartino GN 1995 Primary structures of two homologous subunits of PA28, a gamma-interferon-inducible protein activator of the 20S proteasome. FEBS Lett 366:37-42
9. Nikaido T, Shimada K, Shibata M, Hata M, Sakamoto M, Takasaki Y, Sato C, Takahashi T, Nishida Y 1990 Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with sera from patients with systemic lupus erythematosus. Clin Exp Immunol 79:209-214
10. Rechsteiner M, Realini C, Ustrell V 2000 The proteasome activator 11 S REG (PA28) and class I antigen presentation. Biochem J 345:1-15
11. Luscher B, Eisenman RN 1988 c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock. Mol Cell Biol 8:2504-2512
12. Salvat C, Aquaviva C, Jariel-Encontre I, Ferrara P, Pariat M, Steff AM, Carillo S, Piechaczyk M 1999 Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo? Mol Biol Rep 26:45-51
13. He H, Qi XM, Grossmann J, Distelhorst CW 1998 c-Fos degradation by the proteasome. An early, Bcl-2-regulated step in apoptosis. J Biol Chem 273:25015-25019
14. Glotzer M, Murray AW, Kirschner MW 1991 Cyclin is degraded by the ubiquitin pathway. Nature 349:132-138
15. Moro A, Perea SE, Pantoja C, Santos A, Arana MD, Serrano M 2001 IFNα 2b induces apoptosis and proteasome-mediated degradation of p27Kip1 in a human lung cancer cell line. Oncol Rep 8:425-429
16. Machiels BM, Henfling ME, Broers JL, Hendil KB, Ramekers FC 1995 Changes in immunocytochemical detectability of proteasome epitopes depending on cell growth and fixation conditions of lung cancer cell lines. Eur J Cell Biol 66:282-292
17. Kanayama H, Tanaka K, Aki M, Kagawa S, Miyaji H, Satoh M, Okada F, Sato S, Shimbara N, Ichihara A 1991 Changes in expressions of proteasome and ubiquitin genes in human renal cancer cells. Cancer Res 51:6677-6685
18. Fan XM, Wong BC, Wang WP, Zhou XM, Cho CH, Yuen ST, Leung SY, Lin MC, Kung HF, Lam SK 2001 Inhibition of proteasome function induced apoptosis in gastric cancer. Int J Cancer 93:481-488
19. Bold RJ, Virudachalam S, McConkey DJ 2001 Chemosensitization of pancreatic cancer by inhibition of the 26S proteasome. J Surg Res 100:11-17
20. Tenev T, Marani M, McNeish I, Lemoine NR 2001 Pro-caspase-3 overexpression sensitises ovarian cancer cells to proteasome inhibitors. Cell Death Differ 8:256-264
21. Kumatori A, Tanaka K, Inamura N, Sone S, Ogura T, Matsumoto T, Tachikawa T, Shin S, Ichihara A 1990 Abnormally high expression of proteasomes in human leukemic cells. Proc Natl Acad Sci USA 87:7071-7075
22. Murata S, Kawahara H, Tohma S, Yamamoto K, Kasahara M, Nabeshima Y, Tanaka K, Chiba T 1999 Growth retardation in mice lacking the proteasome activator PA28γ. J Biol Chem 274:38211-38215
23. Taniguchi SO, Shimizu H, Yoshida A, Fukui H, Ueta M, Shigemasa C, Proteasome activator 28-γ (PA28-γ) is induced by growth factors regulating cell cycle of thyrocyte. Proc of the 12th International Thyroid Congress, Kyoto, Japan, 2000
24. Pang XP, Hershman JM, Chung M, Pekary AE 1989 Characterization of tumor necrosis factor-α receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. Endocrinology 125:1783-1788
25. Ito T, Seyama T, Hayashi T, Dohi K, Mizuno T, Iwamoto K, Tsuyama N, Nakamura N, Akiyama M 1994 Establishment of two human thyroid carcinoma cell lines (8305C, 8505C) bearing p53 gene mutations. Int J Oncol 4:583-586
26. Tanaka K, Yoshimura T, Ichihara A, Kameyama K, Takagi T 1986 A high molecular weight protease in the cytosol of rat liver. II. Properties of the purified enzyme. J Biol Chem 261:15204-15207
27. Tanaka K, Yoshimura T, Ichihara A, Ikai A, Nishigai M, Morimoto Y, Sato M, Tanaka N, Katsube Y, Kameyama K, Takagi T 1988 Molecular organization of a high molecular weight multi-protease complex from rat liver. J Mol Biol 203:985-996
28. Fujiwara T, Tanaka K, Kumatori A, Shin S, Yoshimura T, Ichihara A, Tokunaga F, Aruga R, Iwanaga S, Kakizuka A, Nakanishi S 1989 Molecular cloning of cDNA for proteasomes (multicatalytic proteinase complexes) from rat liver: primary structure of the largest component (C2). Biochemistry 28:7332-7340
29. Kisselev AF, Goldberg AL 2001 Proteasome inhibitors: from research tools to drug candidates. Chem Biol 8:739-758
30. Dick LR, Cruikshank AA, Grenier L, Melandri FD, Nunes SL, Stein RL 1996 Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin β-lactone. J Biol Chem 271:7273-7276
31. Ma CP, Slaughter CA, DeMartino GN 1992 Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J Biol Chem 267:10515-10523
32. Dubiel W, Pratt G, Ferrell K, Rechsteiner M 1992 Purification of an 11 S regulator of the multicatalytic protease. J Biol Chem 267:22369-22377
33. Shimizu T, Usuda N, Yamanda T, Sugenoya A, Iida F 1993 Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies. Cancer 71:2807-2812
34. Erickson LA, Jin L, Wollan PC, Thompson GB, van Heerden J, Lloyd RV 1998 Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Mod Pathol 11:169-174
35. Timler D, Tazbir J, Matejkowska M, Gosek A, Czyz W, Brzezinski J 2001 Expression of proteins: D1 cyclin and Ki-67 in papillary thyroid carcinomas. Folia Histochem Cytobiol 39:201-202
36. Ando H, Funahashi H, Ito M, Imai T, Takagi H 1996 Proliferating cell nuclear antigen expression in papillary thyroid carcinoma. J Clin Pathol 49:657-659
37. Omura K, Nagasato A, Kanehira E, Kinsen H, Amaya S, Kimura K, Kajita T, Nozaki Y, Mizukami Y, Nonomura A, Watanabe Y 1997 Retinoblastoma protein and proliferating-cell nuclear antigen expression as predictors of recurrence in well-differentiated papillary thyroid carcinoma. J Clin Oncol 15:3458-3463
38. Masson P, Andersson O, Petersen UM, Young P 2001 Identification and characterization of a Drosophila nuclear proteasome regulator. A homolog of human 11 S REGγ (PA28γ). J Biol Chem 276:1383-1390
39. Wilk S, Chen WE, Magnusson RP 2000 Properties of the nuclear proteasome activator PA28γ (REGγ). Arch Biochem Biophys 383:265-271
40. Yang G, Zhang Z, Liao J, Seril D, Wang L, Goldstein S, Yang CS 1997 Immunohistochemical studies on Waf1p21, p16, pRb and p53 in human esophageal carcinomas and neighboring epithelia from a high-risk area in northern China. Int J Cancer 72:746-751
41. Takahashi H, Fujita S, Yamabe S, Moriishi T, Okabe H, Tajima Y, Mizuno A 1998 Comparison of proliferating cell nuclear antigen expression in odontogenic keratocyst and ameloblastoma: an immunohistochemical study. Anal Cell Pathol 16:185-192
42. Abdelsayed RA, Guijarro-Rojas M, Ibrahim NA, Sangueza OP 2000 Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53. J Cutan Pathol 27:169-175
43. Piattelli A, Fioroni M, Santinelli A, Rubini C 1998 Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. Oral Oncol 34:408-412
44. Realini C, Jensen CC, Zhang Z, Johnston SC, Knowlton JR, Hill CP, Rechsteiner M 1997 Characterization of recombinant REGα, REGβ, and REGγ proteasome activators. J Biol Chem 272:25483-25492
45. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, Dick L, Hwang D, Goldberg AL 1994 Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761-771
46. Fujiwara T, Tanaka K, Orino E, Yoshimura T, Kumatori A, Tamura T, Chung CH, Nakai T, Yamaguchi K, Shin S 1990 Proteasomes are essential for yeast proliferation. cDNA cloning and gene disruption of two major subunits. J Biol Chem 265:16604-16613
47. Sherr CJ, Roberts JM 1999 CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512
48. Basolo F, Pinchera A, Fugazzola L, Fontanini G, Elisei R, Romei C, Pacini F 1994 Expression of p21 ras protein as a prognostic factor in papillary thyroid cancer. Eur J Cancer 2:171-174